MetLife Investment Management’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $160K | Sell |
|
|||||
|
2025
Q2 | $124K | Buy |
|
|||||
|
2025
Q1 | $92.8K | Sell |
|
|||||
|
2024
Q4 | $197K | Buy |
|
|||||
|
2024
Q3 | $314K | Hold |
|
|||||
|
2024
Q2 | $610K | Buy |
|
|||||
|
2024
Q1 | $672K | Hold |
|
|||||
|
2023
Q4 | $427K | Hold |
|
|||||
|
2023
Q3 | $269K | Buy |
|
|||||
|
2023
Q2 | $314K | Hold |
|
|||||
|
2023
Q1 | $299K | Hold |
|
|||||
|
2022
Q4 | $386K | Hold |
|
|||||
|
2022
Q3 | $140K | Hold |
|
|||||
|
2022
Q2 | $121K | Hold |
|
|||||
|
2022
Q1 | $263K | Buy |
|
|||||
|
2021
Q4 | $245K | Buy |
|
|||||
|
2021
Q3 | $215K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $177K | Buy |
|